Variant report
Variant | nsv966994 |
---|---|
Chromosome Location | chr3:17915628-17921392 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:71)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr3:17918969-17919090 | K562 | blood: | n/a | n/a |
2 | BHLHE40 | chr3:17918916-17919202 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr3:17916110-17916367 | K562 | blood: | n/a | chr3:17916286-17916295 chr3:17916343-17916355 chr3:17916285-17916296 chr3:17916284-17916295 |
4 | CEBPB | chr3:17916173-17916714 | K562 | blood: | n/a | chr3:17916286-17916295 chr3:17916343-17916355 chr3:17916285-17916296 chr3:17916284-17916295 |
5 | CEBPB | chr3:17916139-17916455 | MCF-7 | breast: | n/a | chr3:17916286-17916295 chr3:17916343-17916355 chr3:17916285-17916296 chr3:17916284-17916295 |
6 | CEBPB | chr3:17916131-17916716 | A549 | lung: | n/a | chr3:17916286-17916295 chr3:17916343-17916355 chr3:17916285-17916296 chr3:17916284-17916295 |
7 | CEBPB | chr3:17916130-17916682 | Hela-S3 | cervix: | n/a | chr3:17916286-17916295 chr3:17916343-17916355 chr3:17916285-17916296 chr3:17916284-17916295 |
8 | CEBPB | chr3:17916129-17916727 | HepG2 | liver: | n/a | chr3:17916286-17916295 chr3:17916343-17916355 chr3:17916285-17916296 chr3:17916284-17916295 |
9 | CEBPB | chr3:17916138-17916681 | IMR90 | lung: | n/a | chr3:17916286-17916295 chr3:17916343-17916355 chr3:17916285-17916296 chr3:17916284-17916295 |
10 | CTCF | chr3:17918953-17919022 | GM12892 | blood: | n/a | n/a |
11 | CTCF | chr3:17918924-17919071 | MCF-7 | breast: | n/a | n/a |
12 | CTCF | chr3:17918923-17919064 | MCF-7 | breast: | n/a | n/a |
13 | CTCF | chr3:17918948-17919007 | GM19239 | blood: | n/a | n/a |
14 | CTCF | chr3:17918840-17918990 | K562 | blood: | n/a | n/a |
15 | CTCF | chr3:17918880-17919030 | GM12869 | blood: | n/a | n/a |
16 | CTCF | chr3:17918970-17919007 | GM12891 | blood: | n/a | n/a |
17 | CTCF | chr3:17918819-17919154 | K562 | blood: | n/a | n/a |
18 | CTCF | chr3:17918935-17919066 | A549 | lung: | n/a | n/a |
19 | CTCF | chr3:17918793-17919167 | K562 | blood: | n/a | n/a |
20 | CTCF | chr3:17918975-17918985 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | CTCF | chr3:17918905-17919060 | MCF-7 | breast: | n/a | n/a |
22 | CTCF | chr3:17918957-17919007 | GM19238 | blood: | n/a | n/a |
23 | CTCF | chr3:17915979-17916015 | Kidney_OC | kidney: | n/a | n/a |
24 | CTCF | chr3:17918872-17919141 | K562 | blood: | n/a | n/a |
25 | CTCF | chr3:17919020-17919170 | A549 | lung: | n/a | n/a |
26 | CTCF | chr3:17918920-17919070 | K562 | blood: | n/a | n/a |
27 | CTCF | chr3:17918944-17919024 | GM19240 | blood: | n/a | n/a |
28 | CTCF | chr3:17918904-17919057 | MCF-7 | breast: | n/a | n/a |
29 | CTCF | chr3:17918882-17919106 | K562 | blood: | n/a | n/a |
30 | CTCF | chr3:17918860-17919010 | MCF-7 | breast: | n/a | n/a |
31 | CTCF | chr3:17918868-17919182 | K562 | blood: | n/a | n/a |
32 | CTCF | chr3:17918892-17919083 | MCF-7 | breast: | n/a | n/a |
33 | CTCF | chr3:17918880-17919030 | MCF-7 | breast: | n/a | n/a |
34 | CTCF | chr3:17918906-17919016 | HepG2 | liver: | n/a | n/a |
35 | EP300 | chr3:17919089-17919124 | K562 | blood: | n/a | n/a |
36 | FOS | chr3:17916150-17916350 | MCF10A-Er-Src | breast: | n/a | chr3:17916235-17916244 |
37 | FOS | chr3:17916234-17916359 | MCF10A-Er-Src | breast: | n/a | chr3:17916235-17916244 |
38 | FOS | chr3:17916159-17916374 | MCF10A-Er-Src | breast: | n/a | chr3:17916235-17916244 |
39 | GATA2 | chr3:17916001-17916315 | SH-SY5Y | brain: | n/a | n/a |
40 | GATA3 | chr3:17918894-17919355 | MCF-7 | breast: | n/a | n/a |
41 | GATA3 | chr3:17918959-17919300 | T-47D | breast: | n/a | n/a |
42 | GATA3 | chr3:17916109-17916183 | SH-SY5Y | brain: | n/a | n/a |
43 | GATA3 | chr3:17918896-17919523 | MCF-7 | breast: | n/a | n/a |
44 | JUN | chr3:17916563-17916603 | HepG2 | liver: | n/a | chr3:17916584-17916597 |
45 | JUND | chr3:17918964-17919054 | K562 | blood: | n/a | n/a |
46 | MAFK | chr3:17917974-17918302 | HepG2 | liver: | n/a | n/a |
47 | MAFK | chr3:17917991-17918196 | HepG2 | liver: | n/a | n/a |
48 | MAX | chr3:17918898-17919075 | K562 | blood: | n/a | n/a |
49 | MAX | chr3:17918856-17919140 | K562 | blood: | n/a | n/a |
50 | MAZ | chr3:17918960-17919020 | K562 | blood: | n/a | n/a |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
PDCL3P3 | TF binding region |
ENSG00000213383 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs144651389 | chr3:17915686-17915687 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs183924268 | chr3:17915710-17915711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs557555677 | chr3:17915718-17915719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577072651 | chr3:17915740-17915741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs188470521 | chr3:17915799-17915800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146672044 | chr3:17915809-17915810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs191968397 | chr3:17915827-17915828 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541881265 | chr3:17915828-17915829 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs562143166 | chr3:17915911-17915912 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs572333860 | chr3:17915979-17915980 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs541555669 | chr3:17915999-17916000 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs564525036 | chr3:17916018-17916019 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs184212954 | chr3:17916054-17916055 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs549965956 | chr3:17916071-17916072 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs563595778 | chr3:17916072-17916073 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs188650361 | chr3:17916119-17916120 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs13097638 | chr3:17916131-17916132 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs528174730 | chr3:17916217-17916218 | Weak transcription Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs11439490 | chr3:17916218-17916219 | Weak transcription Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs397796409 | chr3:17916227-17916228 | Weak transcription Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs397809973 | chr3:17916228-17916229 | Weak transcription Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs191615068 | chr3:17916318-17916319 | Weak transcription Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs372469109 | chr3:17916339-17916340 | Weak transcription Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs183710870 | chr3:17916343-17916344 | Weak transcription Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs546447924 | chr3:17916373-17916374 | Weak transcription Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs534317606 | chr3:17916398-17916399 | Weak transcription Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs372239719 | chr3:17916560-17916561 | Weak transcription Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs559879482 | chr3:17916570-17916571 | Weak transcription Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs570972079 | chr3:17916571-17916572 | Weak transcription Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs539662893 | chr3:17916649-17916650 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs556311840 | chr3:17916664-17916665 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs6784611 | chr3:17916665-17916666 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs140215453 | chr3:17916668-17916669 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs542130710 | chr3:17916670-17916671 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs114578901 | chr3:17916696-17916697 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs572406056 | chr3:17916728-17916729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73817393 | chr3:17916738-17916739 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs558297202 | chr3:17916744-17916745 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs578123034 | chr3:17916745-17916746 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs543910531 | chr3:17916754-17916755 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112259578 | chr3:17916788-17916789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs563507719 | chr3:17916817-17916818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529067372 | chr3:17916818-17916819 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542952842 | chr3:17916895-17916896 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs6803185 | chr3:17916934-17916935 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs148364065 | chr3:17916942-17916943 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528019940 | chr3:17916987-17916988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs6803292 | chr3:17917001-17917002 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs368863821 | chr3:17917021-17917022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs115739778 | chr3:17917147-17917148 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:17904200-17936200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr3:17915800-17916200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
3 | chr3:17916000-17917200 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr3:17916200-17916600 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
5 | chr3:17916600-17917200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
6 | chr3:17916800-17918000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr3:17919000-17919200 | Enhancers | K562 | blood |